nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Ocular discomfort—Methotrexate—psoriatic arthritis	0.056	0.056	CcSEcCtD
Naphazoline—Intraocular pressure increased—Prednisolone—psoriatic arthritis	0.0476	0.0476	CcSEcCtD
Naphazoline—Intraocular pressure increased—Triamcinolone—psoriatic arthritis	0.0437	0.0437	CcSEcCtD
Naphazoline—Intraocular pressure increased—Methylprednisolone—psoriatic arthritis	0.0436	0.0436	CcSEcCtD
Naphazoline—Intraocular pressure increased—Betamethasone—psoriatic arthritis	0.0397	0.0397	CcSEcCtD
Naphazoline—Intraocular pressure increased—Dexamethasone—psoriatic arthritis	0.0397	0.0397	CcSEcCtD
Naphazoline—Endophthalmitis—Dexamethasone—psoriatic arthritis	0.0367	0.0367	CcSEcCtD
Naphazoline—Endophthalmitis—Betamethasone—psoriatic arthritis	0.0367	0.0367	CcSEcCtD
Naphazoline—Intraocular pressure increased—Prednisone—psoriatic arthritis	0.0346	0.0346	CcSEcCtD
Naphazoline—Keratitis—Prednisolone—psoriatic arthritis	0.0322	0.0322	CcSEcCtD
Naphazoline—Endophthalmitis—Prednisone—psoriatic arthritis	0.0319	0.0319	CcSEcCtD
Naphazoline—Eye disorder—Auranofin—psoriatic arthritis	0.0308	0.0308	CcSEcCtD
Naphazoline—Keratitis—Dexamethasone—psoriatic arthritis	0.0269	0.0269	CcSEcCtD
Naphazoline—Keratitis—Betamethasone—psoriatic arthritis	0.0269	0.0269	CcSEcCtD
Naphazoline—Mydriasis—Prednisolone—psoriatic arthritis	0.0262	0.0262	CcSEcCtD
Naphazoline—Eye pain—Betamethasone—psoriatic arthritis	0.014	0.014	CcSEcCtD
Naphazoline—Eye pain—Dexamethasone—psoriatic arthritis	0.014	0.014	CcSEcCtD
Naphazoline—Nausea—Auranofin—psoriatic arthritis	0.0139	0.0139	CcSEcCtD
Naphazoline—Sweating—Methylprednisolone—psoriatic arthritis	0.0103	0.0103	CcSEcCtD
Naphazoline—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00988	0.00988	CcSEcCtD
Naphazoline—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00988	0.00988	CcSEcCtD
Naphazoline—Erythema—Prednisolone—psoriatic arthritis	0.00914	0.00914	CcSEcCtD
Naphazoline—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00901	0.00901	CcSEcCtD
Naphazoline—Vision blurred—Prednisolone—psoriatic arthritis	0.00862	0.00862	CcSEcCtD
Naphazoline—Hyperglycaemia—Prednisone—psoriatic arthritis	0.0086	0.0086	CcSEcCtD
Naphazoline—Erythema—Triamcinolone—psoriatic arthritis	0.00841	0.00841	CcSEcCtD
Naphazoline—Erythema—Methylprednisolone—psoriatic arthritis	0.00839	0.00839	CcSEcCtD
Naphazoline—Eye disorder—Betamethasone—psoriatic arthritis	0.00819	0.00819	CcSEcCtD
Naphazoline—Eye disorder—Dexamethasone—psoriatic arthritis	0.00819	0.00819	CcSEcCtD
Naphazoline—Hypertension—Prednisolone—psoriatic arthritis	0.00789	0.00789	CcSEcCtD
Naphazoline—Discomfort—Prednisolone—psoriatic arthritis	0.00769	0.00769	CcSEcCtD
Naphazoline—Erythema—Betamethasone—psoriatic arthritis	0.00763	0.00763	CcSEcCtD
Naphazoline—Erythema—Dexamethasone—psoriatic arthritis	0.00763	0.00763	CcSEcCtD
Naphazoline—Hypertension—Triamcinolone—psoriatic arthritis	0.00726	0.00726	CcSEcCtD
Naphazoline—Hypertension—Methylprednisolone—psoriatic arthritis	0.00724	0.00724	CcSEcCtD
Naphazoline—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00721	0.00721	CcSEcCtD
Naphazoline—Eye disorder—Prednisone—psoriatic arthritis	0.00713	0.00713	CcSEcCtD
Naphazoline—Drowsiness—Methotrexate—psoriatic arthritis	0.00711	0.00711	CcSEcCtD
Naphazoline—Discomfort—Triamcinolone—psoriatic arthritis	0.00707	0.00707	CcSEcCtD
Naphazoline—Discomfort—Methylprednisolone—psoriatic arthritis	0.00706	0.00706	CcSEcCtD
Naphazoline—Sweating—Methotrexate—psoriatic arthritis	0.00681	0.00681	CcSEcCtD
Naphazoline—Erythema—Prednisone—psoriatic arthritis	0.00664	0.00664	CcSEcCtD
Naphazoline—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00663	0.00663	CcSEcCtD
Naphazoline—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00662	0.00662	CcSEcCtD
Naphazoline—Hypertension—Dexamethasone—psoriatic arthritis	0.00659	0.00659	CcSEcCtD
Naphazoline—Hypertension—Betamethasone—psoriatic arthritis	0.00659	0.00659	CcSEcCtD
Naphazoline—Discomfort—Betamethasone—psoriatic arthritis	0.00642	0.00642	CcSEcCtD
Naphazoline—Discomfort—Dexamethasone—psoriatic arthritis	0.00642	0.00642	CcSEcCtD
Naphazoline—Vision blurred—Prednisone—psoriatic arthritis	0.00626	0.00626	CcSEcCtD
Naphazoline—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00602	0.00602	CcSEcCtD
Naphazoline—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00602	0.00602	CcSEcCtD
Naphazoline—Eye disorder—Methotrexate—psoriatic arthritis	0.00596	0.00596	CcSEcCtD
Naphazoline—Hypertension—Prednisone—psoriatic arthritis	0.00574	0.00574	CcSEcCtD
Naphazoline—Discomfort—Prednisone—psoriatic arthritis	0.00559	0.00559	CcSEcCtD
Naphazoline—Erythema—Methotrexate—psoriatic arthritis	0.00555	0.00555	CcSEcCtD
Naphazoline—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00524	0.00524	CcSEcCtD
Naphazoline—Vision blurred—Methotrexate—psoriatic arthritis	0.00523	0.00523	CcSEcCtD
Naphazoline—Dizziness—Prednisolone—psoriatic arthritis	0.00493	0.00493	CcSEcCtD
Naphazoline—Asthenia—Triamcinolone—psoriatic arthritis	0.00492	0.00492	CcSEcCtD
Naphazoline—Asthenia—Methylprednisolone—psoriatic arthritis	0.00491	0.00491	CcSEcCtD
Naphazoline—Headache—Prednisolone—psoriatic arthritis	0.00467	0.00467	CcSEcCtD
Naphazoline—Discomfort—Methotrexate—psoriatic arthritis	0.00467	0.00467	CcSEcCtD
Naphazoline—Dizziness—Triamcinolone—psoriatic arthritis	0.00454	0.00454	CcSEcCtD
Naphazoline—Dizziness—Methylprednisolone—psoriatic arthritis	0.00453	0.00453	CcSEcCtD
Naphazoline—Asthenia—Dexamethasone—psoriatic arthritis	0.00447	0.00447	CcSEcCtD
Naphazoline—Asthenia—Betamethasone—psoriatic arthritis	0.00447	0.00447	CcSEcCtD
Naphazoline—Nausea—Prednisolone—psoriatic arthritis	0.00443	0.00443	CcSEcCtD
Naphazoline—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00438	0.00438	CcSEcCtD
Naphazoline—Headache—Triamcinolone—psoriatic arthritis	0.0043	0.0043	CcSEcCtD
Naphazoline—Headache—Methylprednisolone—psoriatic arthritis	0.00429	0.00429	CcSEcCtD
Naphazoline—Dizziness—Dexamethasone—psoriatic arthritis	0.00412	0.00412	CcSEcCtD
Naphazoline—Dizziness—Betamethasone—psoriatic arthritis	0.00412	0.00412	CcSEcCtD
Naphazoline—Nausea—Triamcinolone—psoriatic arthritis	0.00408	0.00408	CcSEcCtD
Naphazoline—Nausea—Methylprednisolone—psoriatic arthritis	0.00407	0.00407	CcSEcCtD
Naphazoline—Somnolence—Methotrexate—psoriatic arthritis	0.00403	0.00403	CcSEcCtD
Naphazoline—Headache—Dexamethasone—psoriatic arthritis	0.0039	0.0039	CcSEcCtD
Naphazoline—Headache—Betamethasone—psoriatic arthritis	0.0039	0.0039	CcSEcCtD
Naphazoline—Asthenia—Prednisone—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Naphazoline—Nausea—Betamethasone—psoriatic arthritis	0.0037	0.0037	CcSEcCtD
Naphazoline—Nausea—Dexamethasone—psoriatic arthritis	0.0037	0.0037	CcSEcCtD
Naphazoline—Dizziness—Prednisone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Naphazoline—Headache—Prednisone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Naphazoline—Asthenia—Methotrexate—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Naphazoline—Nausea—Prednisone—psoriatic arthritis	0.00322	0.00322	CcSEcCtD
Naphazoline—Dizziness—Methotrexate—psoriatic arthritis	0.003	0.003	CcSEcCtD
Naphazoline—Headache—Methotrexate—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Naphazoline—Nausea—Methotrexate—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
